Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

This study is ongoing, but not recruiting participants.

Study NCT00708162 Information provided by Gilead Sciences

First Received: June 30, 2008 Last Updated: February 10, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2014
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: August 23, 2011